Adoptive transfer of tumor-infiltrating lymphocytes may be less effective in patients with metastatic melanoma
Mentally stimulating jobs linked to lower risk of dementia in old age
18 August 2021New Zealand says it has solved Covid outbreak ‘puzzle’
19 August 2021Adoptive transfer of tumor-infiltrating lymphocytes may be less effective in patients with metastatic melanoma
Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as well to an investigational therapy that involves the adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TIL) as patients naïve to these treatments, according to results of a study published in Clinical Cancer Research.
